Literature DB >> 25118979

Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Young Eun Chon1, Kyu Sik Jung, Kwang Joon Kim, Dong Jin Joo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim.   

Abstract

BACKGROUND/AIMS: The controlled attenuation parameter (CAP) is a noninvasive method of assessing hepatic steatosis. We defined the normal range of CAP values in healthy subjects and evaluated the associated factors.
METHODS: CAP values were measured in a cohort of healthy subjects who were screened as living liver transplantation donors and those who underwent health checkups. Subjects with current or a history of chronic liver disease, abnormalities on liver-related laboratory tests, or fatty liver on ultrasonography or biopsy were excluded.
RESULTS: The mean age of the 264 recruited subjects (131 males and 133 females; 76 potential liver donors and 188 subjects who had undergone health checkups) was 49.2 years. The mean CAP value was 224.8 ± 38.7 dB/m (range 100.0-308.0 dB/m), and the range of normal CAP values (5th-95th percentiles) was 156.0-287.8 dB/m. The mean CAP value was significantly higher in the health checkup than in the potential liver donor group (227.5 ± 42.0 vs. 218.2 ± 28.3 dB/m, P = 0.040). CAP values did not differ significantly according to gender or age in either group (all P > 0.05). In a multivariate linear regression analysis, body mass index (β = 0.271, P = 0.024) and triglyceride levels (β = 0.348, P = 0.008) were found to be independently associated with CAP values.
CONCLUSION: We determined the normal range of CAP values and found that body mass index and triglyceride levels were associated with the CAP values of healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25118979     DOI: 10.1007/s10620-014-3293-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.

Authors:  M Sasso; I Tengher-Barna; M Ziol; V Miette; C Fournier; L Sandrin; R Poupon; A-C Cardoso; P Marcellin; C Douvin; V de Ledinghen; J-C Trinchet; M Beaugrand
Journal:  J Viral Hepat       Date:  2011-10-13       Impact factor: 3.728

3.  "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country.

Authors:  Kausik Das; Rajib Sarkar; Sk Mahiuddin Ahmed; Asit R Mridha; Partha S Mukherjee; Kshaunish Das; Gopal K Dhali; Amal Santra; Abhijit Chowdhury
Journal:  Hepatology       Date:  2011-12-29       Impact factor: 17.425

Review 4.  Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.

Authors:  K Gariani; J Philippe; F R Jornayvaz
Journal:  Diabetes Metab       Date:  2012-12-23       Impact factor: 6.041

5.  One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.

Authors:  Charlotte K Ryan; Lesley A Johnson; Barbara I Germin; Amadeo Marcos
Journal:  Liver Transpl       Date:  2002-12       Impact factor: 5.799

6.  Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Julien Vergniol; Grace Lai-Hung Wong; Juliette Foucher; Anthony Wing-Hung Chan; Faiza Chermak; Paul Cheung-Lung Choi; Wassil Merrouche; Shirley Ho-Ting Chu; Sophie Pesque; Henry Lik-Yuen Chan; Victor de Lédinghen
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

Review 7.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

8.  Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

Authors:  H L-Y Chan; G L-H Wong; P C-L Choi; A W-H Chan; A M-L Chim; K K-L Yiu; F K-L Chan; J J-Y Sung; V W-S Wong
Journal:  J Viral Hepat       Date:  2008-07-28       Impact factor: 3.728

9.  Intercontinental differences in overweight of adopted Koreans in the United States and Europe.

Authors:  Stanley Ulijaszek; Daniel Schwekendiek
Journal:  Econ Hum Biol       Date:  2012-09-23       Impact factor: 2.184

10.  Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation.

Authors:  Seung Up Kim; Ja Kyung Kim; Young Nyun Park; Kwang-Hyub Han
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

View more
  8 in total

1.  Fat and fiber: how the controlled attenuation parameter complements noninvasive assessment of liver fibrosis.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective.

Authors:  Ki Hyun Kim; Yoonhong Kim; Kwang Il Seo; Kyung Won Seo
Journal:  Ann Surg Treat Res       Date:  2022-06-07       Impact factor: 1.766

3.  Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients.

Authors:  Nirav K Desai; Sarah Harney; Roshan Raza; Alyaa Al-Ibraheemi; Nick Shillingford; Paul D Mitchell; Maureen M Jonas
Journal:  J Pediatr       Date:  2016-03-30       Impact factor: 4.406

4.  Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model.

Authors:  Hyunsoo Chung; Young Eun Chon; Seung Up Kim; Sang Kil Lee; Kyu Sik Jung; Kwang-Hyub Han; Chae Yoon Chon
Journal:  Dig Dis Sci       Date:  2015-10-06       Impact factor: 3.199

5.  Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.

Authors:  Dieter Broering; Mohamed Shawkat; Ali Albenmousa; Faisal Abaalkhail; Saleh Alabbad; Waleed Al-Hamoudi; Saad Alghamdi; Saleh Alqahthani; Ahmad Jaafari; Roberto Troisi; Khalid Bzeizi
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

6.  Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta.

Authors:  Carolina Chaves; Eveline Bruinstroop; Samuel Refetoff; Paul M Yen; João Anselmo
Journal:  Thyroid       Date:  2021-02-19       Impact factor: 6.506

7.  Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.

Authors:  Jeong-Ju Yoo; Yang Jae Yoo; Woo Ram Moon; Seung Up Kim; Soung Won Jeong; Ha Na Park; Min Gyu Park; Jae Young Jang; Su Yeon Park; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Sang Gyune Kim; Young Seok Kim; Ji Hoon Kim; Jong Eun Yeon; Kwan Soo Byun
Journal:  Korean J Intern Med       Date:  2019-11-08       Impact factor: 2.884

8.  Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Hye Won Lee; Soo Young Park; Seung Up Kim; Jae Young Jang; Hana Park; Ja Kyung Kim; Chun Kyon Lee; Young Eun Chon; Kwang-Hyub Han
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.